Novartis Dividend Yield from 2010 to 2025

NVS Stock  USD 97.53  0.33  0.34%   
Novartis Dividend Yield yearly trend continues to be comparatively stable with very little volatility. Dividend Yield will likely drop to 0.02 in 2025. Dividend Yield is a financial ratio that shows how much Novartis AG ADR pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. View All Fundamentals
 
Dividend Yield  
First Reported
2010-12-31
Previous Quarter
0.031
Current Value
0.0241
Quarterly Volatility
0.00757104
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novartis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novartis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10 B, Interest Expense of 550.6 M or Selling General Administrative of 17.3 B, as well as many indicators such as Price To Sales Ratio of 3.86, Dividend Yield of 0.0241 or PTB Ratio of 3.23. Novartis financial statements analysis is a perfect complement when working with Novartis Valuation or Volatility modules.
  
Check out the analysis of Novartis Correlation against competitors.

Latest Novartis' Dividend Yield Growth Pattern

Below is the plot of the Dividend Yield of Novartis AG ADR over the last few years. Dividend Yield is Novartis AG ADR dividend as a percentage of Novartis stock price. Novartis AG ADR dividend yield is a measure of Novartis stock productivity, which can be interpreted as interest rate earned on an Novartis investment. It is a financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Novartis' Dividend Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novartis' overall financial position and show how it may be relating to other accounts over time.
Dividend Yield10 Years Trend
Pretty Stable
   Dividend Yield   
       Timeline  

Novartis Dividend Yield Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.03
Coefficient Of Variation21.79
Mean Deviation0.01
Median0.04
Standard Deviation0.01
Sample Variance0.000057
Range0.0303
R-Value(0.13)
Mean Square Error0.00006
R-Squared0.02
Significance0.63
Slope(0.0002)
Total Sum of Squares0.0009

Novartis Dividend Yield History

2025 0.0241
2024 0.031
2023 0.0344
2022 0.0381
2021 0.0373
2020 0.0325
2019 0.0306

About Novartis Financial Statements

Novartis shareholders use historical fundamental indicators, such as Dividend Yield, to determine how well the company is positioned to perform in the future. Although Novartis investors may analyze each financial statement separately, they are all interrelated. The changes in Novartis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Novartis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Dividend Yield 0.03  0.02 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Novartis Stock Analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.